(SLE)
ZALIFRELIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CTLA4 (CYTOTOXIC TLYMPHOCYTE- ASSOCIATED PROTEIN 4, CD152)], HOMO SAPIENS MONOCLONAL ANTIBODY;GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-448) [VH (HOMO SAPIENS IGHV3-21*01 (100%) -(IGHD) -IGHJ3*02 (100%)) [8.8.11] (1-118) -HOMO SAPIENS IGHG1*03 (100%) (CH1 R120 (215) (119-216), HINGE (217-231), CH2 (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)], (221-214')- DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') [V-KAPPA (HOMO SAPIENS IGKV3-20*01 (94.8%) -IGKJ1*01 (100%)) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (227-227'':230-230'')-BISDISULFIDE. PROPOSED INN: LIST 120; REC. INN LIST 82; REC. INN LIST 83(WHOM)
ZALIFRELIMABUM(INN)